Oclacitinib maleate is a synthetic cyclohexylamino pyrrolopyrimidine compound that functions as a janus kinase inhibitor, primarily used in veterinary medicine. It is supplied as an active pharmaceutical ingredient for the manufacture of formulations intended to control pruritus associated with allergic dermatitis in dogs.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing OCLACITINIB MALEATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
OCLACITINIB MALEATE
pharmaceutical raw material
Oclacitinib
active pharmaceutical ingredient for veterinary use
Amprolium chloride
pharmaceutical raw material
Benzethonium chloride
pharmaceutical raw material
Nelarabine
pharmaceutical raw material
Ertugliflozin
pharmaceutical raw material
The international HS code for OCLACITINIB MALEATE (CAS 1208319-27-0) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide
VQIGDTLRBSNOBV-BTJKTKAUSA-N
CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3.C(=C\C(=O)O)\C(=O)O
Sourcing OCLACITINIB MALEATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.